Stocks · News reference

HC Wainwright & Co. Maintains Buy on Aura Biosciences, Lowers Price Target to $18

Aug 11, 2026, 4:11 PMBenzinga Newsdesk

HC Wainwright & Co. analyst Andres Y. Maldonado maintains Aura Biosciences (NASDAQ:AURA) with a Buy and lowers the price target from $24 to $18.

More stocks news Connected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: benzinga
Observed: Aug 11, 2026, 4:11 PM
Checked: Aug 11, 2026, 4:11 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 12, 2026, 12:00 PMBenzinga Newsdesk
Auro Biosciences shares are trading lower after the company announced it may offer securities up to an aggregate of $500 million and may sell up to $200 million shares under a sales agreement with Jefferies.
AURA
BenzingaAug 11, 2026, 8:56 PMBenzinga Newsdesk
Aura Biosciences May Offer Securities Up To $500M Aggregate; May Sell Up To $200M Common Stock Under Sales Agreement With Jefferies
- Sec Filing
AURA
BenzingaAug 11, 2026, 11:22 AMBenzinga Newsdesk
Aura Biosciences Q2 EPS $(0.48) Misses $(0.38) Estimate
Aura Biosciences (NASDAQ:AURA) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.38) by 29.73 percent. This is a 2.13 percent decrease over losses of $(0.47) per share
AURA